Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kane Biotech Inc KNBIF


Primary Symbol: V.KNE

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more

Recent & Breaking News (TSXV:KNE)

Kane Biotech Announces Conditional Research Award of Up To $3.4 Million

GlobeNewswire December 3, 2019

Kane Biotech to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

GlobeNewswire December 2, 2019

Kane Biotech Engages Kilmer Lucas for Cross-Border Investor Relations

GlobeNewswire November 26, 2019

Kane Biotech Announces Third Quarter 2019 Financial Results

GlobeNewswire November 14, 2019

Kane Biotech Announces Date of Q3 Earnings Release

GlobeNewswire November 6, 2019

Kane Biotech Retains GR Consulting to Identify Potential Partnerships for its Proprietary DispersinB® Wound Care Hydrogel

GlobeNewswire October 31, 2019

Kane Biotech and Dechra Veterinary Products Expand Exclusive License and Distribution Agreement to Include South America

GlobeNewswire October 16, 2019

Kane Biotech Receives Funding for Research and Development

GlobeNewswire October 8, 2019

Kane Biotech Releases Inaugural Business Update Video

GlobeNewswire September 10, 2019

Kane Biotech Announces Second Quarter 2019 Financial Results

GlobeNewswire August 21, 2019

Kane Biotech Announces Q2 Earnings Release and Inaugural Business Update Video

GlobeNewswire August 14, 2019

Kane Biotech Announces Share Purchase by CEO, Exercise of Warrants, Reimbursement of Insider Advances and Extension of Loan

GlobeNewswire August 13, 2019

Kane Biotech Strengthens Team with New Additions in Animal Health and Quality Assurance

GlobeNewswire August 12, 2019

IIROC Trading Resumption - KNE

Canada NewsWire August 6, 2019

Kane Biotech Awarded $3.8 Million in Non-Dilutive Government Funding

GlobeNewswire August 6, 2019

IIROC Trading Halt - KNE

Canada NewsWire August 6, 2019

Kane Biotech Announces New Funding Granted from CanExport Program

GlobeNewswire August 1, 2019

Kane Biotech Announces Exclusive Distribution Agreement with Eetoys Pet Products Limited

GlobeNewswire July 18, 2019

Kane Biotech Announces New Agreement with FreeMind Group

GlobeNewswire July 16, 2019

Kane Biotech Secures Large Order from Leading Quebec Retailer

GlobeNewswire June 25, 2019